Abstract
Over the past few decades, pediatric obesity has become a national epidemic. Up to one third of American children and adolescents currently meet criteria as overweight or obese, placing them at risk for obesity into adulthood. Multiple acute and chronic medical conditions are increasing in prevalence among youth due to their overweight status. In addition, obesity can result in serious problems related to psychosocial functioning. Efforts at prevention and treatment must address the multifactorial causes and consequences of pediatric obesity. Though many programs have been proposed, more work is needed in this area to successfully combat the problem of pediatric obesity.
Keywords: Children, adolescents, overweight, obesity, prevention, treatment, review, apnea, psychosocial, multifactorial, Epidemiology, stereotyped, Complications, arthritis, ischemic stroke, polycystic, nonalcoholic, metabolic, gallstones, Musculoskeletal, Orthopedic
Current Pharmaceutical Design
Title: Pediatric Obesity Epidemic: Problem and Solutions
Volume: 17 Issue: 12
Author(s): Lisa J. Merlo and Heather L. Yardley
Affiliation:
Keywords: Children, adolescents, overweight, obesity, prevention, treatment, review, apnea, psychosocial, multifactorial, Epidemiology, stereotyped, Complications, arthritis, ischemic stroke, polycystic, nonalcoholic, metabolic, gallstones, Musculoskeletal, Orthopedic
Abstract: Over the past few decades, pediatric obesity has become a national epidemic. Up to one third of American children and adolescents currently meet criteria as overweight or obese, placing them at risk for obesity into adulthood. Multiple acute and chronic medical conditions are increasing in prevalence among youth due to their overweight status. In addition, obesity can result in serious problems related to psychosocial functioning. Efforts at prevention and treatment must address the multifactorial causes and consequences of pediatric obesity. Though many programs have been proposed, more work is needed in this area to successfully combat the problem of pediatric obesity.
Export Options
About this article
Cite this article as:
J. Merlo Lisa and L. Yardley Heather, Pediatric Obesity Epidemic: Problem and Solutions, Current Pharmaceutical Design 2011; 17 (12) . https://dx.doi.org/10.2174/138161211795656756
DOI https://dx.doi.org/10.2174/138161211795656756 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Curcumin Activates Erythrocyte Membrane Acetylcholinesterase
Letters in Drug Design & Discovery Other Potential Therapeutic Targets in Thyroid Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Gender Specific Aspects of Cell Death in the Cardiovascular System
Current Pharmaceutical Design Heterozygosity in LDLR rs2228671 and rs72658855 Gene is Associated with Increased Risk of Developing Coronary Artery Disease in India –A Case-Control Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Evaluation of the Risk/Benefit Ratio of Old and New Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pharmacological Roles of the Large-Conductance Calcium-Activated Potassium Channel
Current Topics in Medicinal Chemistry Chronic Kidney Disease and Thrombosis
Current Pediatric Reviews Gastrophysics of the Oral Cavity
Current Pharmaceutical Design Preface [Hot Topic: Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
Current Pharmaceutical Design Modifiable Risk Factors for Premature Atherosclerosis in Systemic Lupus Erythematosus
Vascular Disease Prevention (Discontinued) Cardiovascular Risk Factors: Does Sex Matter?
Current Vascular Pharmacology Atherosclerosis, Degenerative Aortic Stenosis and Statins
Current Drug Targets Thioredoxin-1 is a Novel and Attractive Therapeutic Approach for Various Diseases Including Cardiovascular Disorders
Cardiovascular & Hematological Disorders-Drug Targets New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design Pathophysiological Basis for Anticoagulant and Antithrombotic Therapy in Pulmonary Hypertension
Cardiovascular & Hematological Agents in Medicinal Chemistry The Therapeutic Potential of Rutin for Diabetes: An Update
Mini-Reviews in Medicinal Chemistry Coronary Artery Disease and End-Stage Renal Disease - A Clinical Perspective
Current Hypertension Reviews Gender Bias in Acute Coronary Syndromes
Current Vascular Pharmacology Flavonoids and Linderone from Lindera oxyphylla and their Bioactivities
Combinatorial Chemistry & High Throughput Screening Vascular Inflammation in Hypertension: Targeting Lipid Mediators Unbalance and Nitrosative Stress
Current Hypertension Reviews